Phase II Clinical Study of the Combination Chemotherapy Regimen of Irinotecan Plus Oral Etoposide for the Treatment of Recurrent Ovarian Cancer (Tohoku Gynecologic Cancer Unit 101 Group Study)Tadahiro Shoji, Toru Sugiyama, Akira Yoshizaki et al.|International Journal of Gynecological Cancer|2010Cited by 18
Investigation of the clinicopathological features of fallopian tube malignancyYoshihito Yokoyama, Hideki Mizunuma, Masayuki Futagami et al.|Oncology Reports|2013Cited by 5